Cancer of the esophagus. An incidence study of Côte d'Or (Burgundy).

Abstract:

:The registry of digestive cancer set up for the French department of Côte d'Or (455, 727) enables a morbidity study about esophageal cancer to be made among residents. The crude animal incidence rate was 16.7/100,000 for males and 1.2/100,000 for females. Corresponding age-standardized rates were 13.2 and 0.5. The sex ratio is extremely high. Among other cancer registries Côte d'Or is in the intermediate range for males, and in the low range for females. 40% of tumors were in the middle third, 37% in the lower third, and 23% in the upper third. Most cancers were squamous cell carcinomas (94%). The risk of an associated aerodigestive tract tumor is important (16%). 10% of patients were operated upon for cure, 53% had radiotherapy. The 1 year crude survival rate was 25%.

journal_name

Oncology

journal_title

Oncology

authors

Faivre J,Milan C,Martin F,Michiels R,Cabanne F,Klepping C

doi

10.1159/000225510

subject

Has Abstract

pub_date

1981-01-01 00:00:00

pages

1-3

issue

1

eissn

0030-2414

issn

1423-0232

journal_volume

38

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.

    abstract:BACKGROUND/AIM:Erlotinib and chemotherapy have shown similar efficacy for pretreated non-small cell lung cancer (NSCLC) patients, but none of the large studies have selected patients based on histology. We present a retrospective single-center series of advanced non-squamous NSCLC patients treated with erlotinib or pem...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000346534

    authors: Zugazagoitia J,Puente J,González-Larriba JL,Manzano A,Sotelo M,Hernández S,Sanz J,Pérez P,Díaz-Rubio E

    更新日期:2013-01-01 00:00:00

  • Treatment of hepatocellular carcinoma with Child-Pugh C cirrhosis.

    abstract:BACKGROUND:In most guidelines, no other interventional therapy but liver transplantation is recommended for the treatment of hepatocellular carcinoma (HCC) with Child-Pugh C cirrhosis (CP-C). However, in Japan, patients were sometimes treated with expectation of benefit. SUMMARY:A workshop was conducted to explore the...

    journal_title:Oncology

    pub_type:

    doi:10.1159/000368152

    authors: Nouso K,Kokudo N,Tanaka M,Kuromatsu R,Nishikawa H,Toyoda H,Oishi N,Kuwaki K,Kusanaga M,Sakaguchi T,Morise Z,Kitai S,Kudo M

    更新日期:2014-01-01 00:00:00

  • Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.

    abstract::We evaluated changes in serum albumin concentrations in 15 patients with advanced malignancy who were also receiving cisplatin. All 15 patients had serial measurements of serum albumin. The decrease in serum albumin from the time of the first dose of cisplatin to death correlated with liver platinum levels at autopsy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226100

    authors: Nanji AA,Mikhael NZ,Stewart DJ

    更新日期:1986-01-01 00:00:00

  • Modern Information Technology for Cancer Research: What's in IT for Me? An Overview of Technologies and Approaches.

    abstract::Information technology (IT) can enhance or change many scenarios in cancer research for the better. In this paper, we introduce several examples, starting with clinical data reuse and collaboration including data sharing in research networks. Key challenges are semantic interoperability and data access (including data...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000493638

    authors: Ahlbrandt J,Lablans M,Glocker K,Stahl-Toyota S,Maier-Hein K,Maier-Hein L,Ückert F

    更新日期:2020-01-01 00:00:00

  • Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.

    abstract::Our previous trial with a docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen showed high response rates in metastatic squamous cell carcinoma of the esophagus (SCCE). The observed increased toxicity of the DCF regimen, however, was clinically harmful. S-1, an oral anticancer drug, has been approved as a combinatio...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000488861

    authors: Ojima T,Nakamura M,Nakamori M,Katsuda M,Hayata K,Maruoka S,Shimokawa T,Yamaue H

    更新日期:2018-01-01 00:00:00

  • Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

    abstract:OBJECTIVE:Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables. METHODS AND RESULTS:Univariate, multivariate, and elastic net modeling...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000442710

    authors: Jatoi A,Vierkant RA,Hawthorne KM,Block MS,Ramus SJ,Larson NB,Fridley BL,Goode EL

    更新日期:2016-01-01 00:00:00

  • Anticipatory nausea and vomiting: prevalence and predictors in chemotherapy patients.

    abstract::One hundred and seventy-five patients selected at random were prospectively studied. All patients were assessed at least after the first cycle of treatment by a self-report questionnaire which covered the occurrence of nausea and vomiting 24 before chemotherapy, as well as information regarding 22 clinical parameters....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226675

    authors: Alba E,Bastus R,de Andres L,Sola C,Paredes A,Lopez Lopez JJ

    更新日期:1989-01-01 00:00:00

  • Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.

    abstract::Twenty-seven patients with advanced measurable colorectal carcinoma were treated with a combination protocol consisting of folinic acid (FA) 200 mg/m2 i.v. bolus followed by 5-fluorouracil (5-FU) 550 mg/m2, and cisplatin (CIS) 20 mg/m2 each administered as a 2-hour i.v. infusion. Treatment was given on 4 consecutive d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226719

    authors: Scheithauer W,Depisch D,Schiessel R,Ludwig H

    更新日期:1989-01-01 00:00:00

  • Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.

    abstract:OBJECTIVE:Our aim is to assess the clinicopathological significance of E-cadherin and beta-catenin expression, as well as their association with apoptosis in gallbladder cancers. METHODS:The expression of E-cadherin and beta-catenin proteins was examined in 4 biliary tract cancer cell lines and 49 gallbladder cancer s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000100478

    authors: Hirata K,Ajiki T,Okazaki T,Horiuchi H,Fujita T,Kuroda Y

    更新日期:2006-01-01 00:00:00

  • Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.

    abstract:BACKGROUND:To date, the clinical characteristics of coronavirus disease 19 (COVID-19)-infected urologic cancer patients are unknown. METHODS:We have analyzed all patients with prostate cancer undergoing hormonal or chemotherapy treatment and receiving telephone and in person pre-triage between March 1 and 27, 2020, at...

    journal_title:Oncology

    pub_type: 新闻

    doi:10.1159/000509434

    authors: Di Lorenzo G,Buonerba L,Ingenito C,Crocetto F,Buonerba C,Libroia A,Sciarra A,Ragone G,Sanseverino R,Iaccarino S,Napodano G,Imbimbo C,Leo E,Kozlakidis Z,De Placido S

    更新日期:2020-01-01 00:00:00

  • The effect of minocin on the pericardium.

    abstract::The purpose of this study was to evaluate in a dog model whether intrapericardial instillation of tetracycline is superior to the effect of drainage alone in causing pericardial adhesions and cavity obliteration. Twelve mongrel dogs were randomly divided into two experimental groups. All dogs received a pericardial dr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227232

    authors: Markiewicz W,Ben-Arieh Y,Best L,Mordochovich D,Rinkevitch D

    更新日期:1993-11-01 00:00:00

  • Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.

    abstract:BACKGROUND:Bladder cancer is the fifth most common cancer among men and the seventh among women. At diagnosis, at least 25% of bladder cancer tumors are locally or systemically advanced. Systemic chemotherapy is the only current modality for advanced or metastatic transitional cell carcinoma of the bladder. Recently, a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000089993

    authors: Adamo V,Magno C,Spitaleri G,Garipoli C,Maisano C,Alafaci E,Adamo B,Rossello R,Scandurra G,Scimone A

    更新日期:2005-01-01 00:00:00

  • Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.

    abstract::Coagulation disorders are frequently detected in patients affected by different tumours even though clinical symptoms occur in a very small percentage of such subjects. Coagulation processes are probably involved in the mechanism of metastatic spread. We assayed the plasma levels of thrombin-antithrombin III (TAT) com...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227086

    authors: Bartoloni C,Guidi L,Tricerri A,Patriarca F,Pili R,Cursi F,Canetta M,Cappelli A,Vangeli M,Salvati F

    更新日期:1992-01-01 00:00:00

  • Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

    abstract::Sodium cyanate, a drug that selectively suppresses amino acid incorporation for protein synthesis in tumor tissue, was given to patients with advanced colorectal carcinoma who had failed to conventional therapy, with the purpose of assessing a maximum tolerable oral dose. At 35 mg/kg p.o. daily, the drug had to be sto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226038

    authors: Herrera-Ornelas L,Petrelli NJ,Madajewicz S,Mittelman A,Allfrey VG

    更新日期:1985-01-01 00:00:00

  • Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial.

    abstract:BACKGROUND:The De Gramont regimen (or high-dose LV5FU2, HD-LV5FU2) is considered a standard treatment for metastatic colorectal cancer. The aim of the study was to evaluate the efficacy and the costs of three regimens as compared to HD-LV5FU2: raltitrexed (R), LV5FU2 with a lower dose of folinic acid (LD-LV5FU2), and w...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000100448

    authors: Borget I,Aupérin A,Pignon JP,Abbas M,Bouché O,Mousseau M,Raoul JL,Bedenne L,Cassan P,Clavero-Fabri MC,Stremsdoerfer N,Nasca S,Queuniet AM,Ducreux M,Fédération Francophone de Cancérologie Digestive.

    更新日期:2006-01-01 00:00:00

  • Serum alphafetoprotein in bladder carcinoma.

    abstract::112 cases, of varying ages, which were diagnosed as having carcinoma of the bladder by cystoscopy and biopsy from the tumor, were investigated for the presence of alphafetoprotein (AFP) in the sera. 59 (52.6%) out of the total, showed positive results, and no false positive results occured. Radioimmunoassay was capabl...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225188

    authors: Alsabti EA

    更新日期:1977-01-01 00:00:00

  • Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.

    abstract:OBJECTIVE:Irinotecan has, in general, been administered as a 90-min infusion. However, several studies have demonstrated that continuous infusion seems to be a promising method of delivering irinotecan. This phase I/II trial was performed to evaluate the efficacy and safety of continuous infusion of irinotecan combined...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000209963

    authors: Sadahiro S,Suzuki T,Maeda Y,Tanaka A,Ishikawa K,Makuuchi H,Murayama C

    更新日期:2009-01-01 00:00:00

  • Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.

    abstract:BACKGROUND:Bevacizumab (Avastin) significantly improves overall survival (OS) and progression-free survival (PFS) when combined with first-line irinotecan (IFL) plus bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer (CRC). This open-label, phase IV trial evaluated the efficac...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000229787

    authors: Sobrero A,Ackland S,Clarke S,Perez-Carrión R,Chiara S,Gapski J,Mainwaring P,Langer B,Young S,AVIRI Trial investigators.

    更新日期:2009-01-01 00:00:00

  • Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer.

    abstract::In order to assess the feasibility of a sequential hormonal treatment after tamoxifen failure, 24 postmenopausal advanced breast cancer patients (median age 60 years; ECOG PS < or = 1) were treated with formestane (4-hydroxyandrostenedione) 250 mg i.m. fortnightly; 19 patients were estrogen receptor-positive. The site...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227510

    authors: Noberasco C,Bajetta E,Zilembo N,Di Leo A,Cappuzzo F,Bartoli C,Bono A,Bichisao E

    更新日期:1995-11-01 00:00:00

  • Ondansetron: a cost-effective advance in anti-emetic therapy.

    abstract::A cost-effectiveness analysis is one form of full economic evaluation where drug acquisition costs and the costs that are incurred as a result of using a particular treatment are assessed together with clinical efficacy. This paper reviews two such studies. One of the studies was a prospective randomised cost-effectiv...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227175

    authors: Cox F,Hirsch J

    更新日期:1993-05-01 00:00:00

  • The trophoblast theory of cancer (John Beard, 1857-1924) revisited.

    abstract::Beard's theory can be restated in a modified form in modern terms in the following way. Cancer represents primarily trophoblastic tissue derived either from an aberrant germ cell or from a somatic cell whose normally repressed 'asexual generation' genes are abnormally reactivated ('derepressed'). The variety of tumors...

    journal_title:Oncology

    pub_type: 传,历史文章,杂志文章

    doi:10.1159/000225037

    authors: Gurchot C

    更新日期:1975-01-01 00:00:00

  • Presence of anti-gamma-FA-reactive antigens in spontaneous and carcinogen-induced malignancies of experimental animals.

    abstract::Immunochemical analysis of various tumors, representing 12 different tissue sites of origin, revealed a gamma-fetal antigen(gamma-FA)-like component in 17 of 23 malignant neoplasms of the mouse. This antigen was identified in extracts of spontaneous and carcinogen-induced murine tumors as well as in extracts of hepati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225584

    authors: Higgins PJ,Tong C,Borenfreund E

    更新日期:1981-01-01 00:00:00

  • Effects of PSK on resistance to bacterial infection in splenectomized mice.

    abstract::Nontumor-bearing C3H/He mice were splenectomized and intravenously inoculated 7 days later with Streptococcus pneumoniae, Pseudomonas aeruginosa, or Escherichia coli. The survival rate was reduced by splenectomy in the animals inoculated with S. pneumoniae, but did not change in those inoculated with P. aeruginosa or ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226566

    authors: Ando T,Motokawa I,Sakurai K,Ohmura Y,Matsunaga K,Fujii T,Yoshikumi C,Taguchi T

    更新日期:1988-01-01 00:00:00

  • Protein accumulation in cultures of hepatic tumor cells exposed to dimethylsulfoxide.

    abstract::The effect of the differentiation-inducing agent dimethylsulfoxide (DMSO) on the protein composition of hepatic tumor cells was evaluated using the BW77-1 line of murine hepatoma cells previously determined to be DMSO-inducible for enhanced liver function. DMSO-mediated suppression of BW77-1 proliferation was accompan...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225850

    authors: Higgins PJ

    更新日期:1984-01-01 00:00:00

  • Detection of early ototoxic effect in testicular-cancer patients treated with cisplatin by transiently evoked otoacoustic emission: a pilot study.

    abstract:UNLABELLED:The outlook for patients with testicular germ cell cancer was dramatically improved by the introduction of cisplatin. Well-known side effects of cisplatin (nausea, vomiting, nephrotoxicity, myelosuppression) can be managed with preventive methods. The long life expectancy after this therapy draws attention t...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227724

    authors: Biró K,Baki M,Büki B,Noszek L,Jókúti L

    更新日期:1997-09-01 00:00:00

  • Progress in surgical treatment of hepatocellular carcinoma.

    abstract::Surgery for hepatocellular carcinoma has improved dramatically during the last two decades, and the improvement is mainly attributable to the development of intraoperative ultrasound-guided operative procedures such as Makuuchi's segmentectomy, introduction of the intermittent vascular occlusion technique, and establi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000048280

    authors: Makuuchi M,Imamura H,Sugawara Y,Takayama T

    更新日期:2002-01-01 00:00:00

  • Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer.

    abstract:BACKGROUND:Patients with localized esophageal and esophagogastric junction cancer (EAC) receive chemoradiation and then surgery (trimodality, TMT) or definitive chemoradiation (bimodality, BMT). Distant metastases (DMs) are common but the details of their distribution and timing in a large cohort have not been describe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360703

    authors: Shiozaki H,Sudo K,Xiao L,Wadhwa R,Elimova E,Hofstetter WL,Skinner HD,Lee JH,Weston B,Bhutani MS,Blum MA,Maru DM,Ajani JA

    更新日期:2014-01-01 00:00:00

  • Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). One of the characteristics of HCV infection is the unusual augmentation of oxidative stress, which is exacerbated by iron accumulation in the liver, as observed frequently in hepatitis C patients. U...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333253

    authors: Fujinaga H,Tsutsumi T,Yotsuyanagi H,Moriya K,Koike K

    更新日期:2011-01-01 00:00:00

  • Lethal exitus of a patient with N-nitrosodimethylamine poisoning, 2.5 years following the first ingestion and signs of intoxication.

    abstract::The report describes the lethal exitus of a 44-year-old woman after repeated criminal poisoning with N-nitrosodimethylamine. She died 32 months following the initial symptoms and developed a liver cirrhosis with multiple bleeding, a hemolytic syndrome and diabetes mellitus. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225451

    authors: Fussgaenger RD,Ditschuneit H

    更新日期:1980-01-01 00:00:00

  • Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.

    abstract:PURPOSE:This phase I study (EudraCT No. 2006-001177-25) investigated aflibercept, a vascular endothelial growth factor decoy receptor protein (VEGF Trap), in combination with docetaxel, cisplatin, and 5-fluorouracil in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received 2, 4, or 6 mg/kg of intr...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000440958

    authors: Bahleda R,Baker J,Massard C,Gadgeel SM,Rogers JE,Izzedine H,Deutsch E,Garris JL,Khan A,Boelle E,Assadourian S,Soria JC,Ajani JA

    更新日期:2016-01-01 00:00:00